From the abstract, a total of 18!-omits technologies, worth a look. https://t.co/hMjCeDlI2p
RT @garius: Right. As a heavy tweeter/content creator who is now maintaining BOTH a Twitter and Mastodon presence, here is a short guide to…
@AlbertVilella Okay, found this https://t.co/2lRVEIF6ho and 17.2MB methylated targets at 139x coverage is about 2.4… https://t.co/ilTnG9Y02H
7:57pm November 4th 2022 via Twitter for iPhone in reply to 0
@AlbertVilella Lastly their COGS have got to be killing them, as the Galleri assay technology is some 5 or 6 years… https://t.co/4M74WNeSJx
7:51pm November 4th 2022 via Twitter for iPhone in reply to 0
@AlbertVilella As you are well aware, clinical trials are expen$ive, I looked it up a while ago and costs roughly (… https://t.co/nlyCEcK0jM
7:49pm November 4th 2022 via Twitter for iPhone in reply to 0
@AlbertVilella IANA financial analyst, but per Investopedia: “Impairment may occur if the assets acquired no longer… https://t.co/mX3FOtKwMs
7:45pm November 4th 2022 via Twitter for iPhone in reply to 0
@AlbertVilella Much appreciated! Great #biobank list BTW, so many projects I had little idea of.
@AlbertVilella @LAbizar One tidbit: "Once the sequencing readout errors were fixed with SBB, you could see easily a… https://t.co/kNXsaF4AhG
@AlbertVilella Hi again - link appears to be broken, can you please provide the correct one? Thx!
@AlbertVilella @LAbizar Hi there Albert! At #ASHG22 I wasn't able to make a PacBio talk (and am friends with Abizar… https://t.co/5uQZtDa3Rg
RT @OlinkProteomics: The latest episode of the Proteomics in Proximity podcast interviews CSO Dr. Ida Grundberg to celebrate our 1000th pee…
RT @OlinkProteomics: ★ Just published a new episode of Proteomics in Proximity: Celebrating 1,000 Olink Publications with Ida Grundberg. Li…
Happy to celebrate @OlinkProteomics 1000th peer-reviewed publication! News item here: https://t.co/Fu3WVhiF9d And a… https://t.co/bpzZR3BsRQ
From one of the links below. "Her current project – under the name SÉN – uses experimental data from living neurons… https://t.co/Z4Ovxp4pAx
Interesting commentary on an ONT presentation at @uppsalauni and the background on the quotation below is here:… https://t.co/tPzM3W1XH9
@walidgellad First point made: I will not buy prestige. Second point made: I will buy prestige.
Nice roundup of weekly goings-on, including Quantum Si's publication in this week's Science, Illumina news (althoug… https://t.co/m0NydwZQOK
A recent effort of mine over on the Olink blog. https://t.co/RVKDIiwKhv
RT @jonathan_flint1: The department of human genetics at UCLA is recruiting and I am the chair of the search committee. Please apply: http…
RT @HeidiRehm: It’s been a long time coming but I am ‘gleeful’ with the news that Myriad Genetics will be submitting all variants to ClinVa…
Some remarkable advice here. Let them have have ears, let them hear. https://t.co/Q9jxaOUDkZ
For those interested in Corporate Facebook circa 2012 and onward, this is for you. Interesting read! https://t.co/mI0f3FmSAM
RT @OlinkProteomics: We are thrilled to be exhibiting and presenting at #SITC2022 November 8 – 12! If you’re coming, you won’t want to miss…
RT @marklewismd: The horror https://t.co/RmIEAri3Dc
RT @EvonneMcArthur: At the end of a great @GeneticsSociety #ASHG22, I wanted to share & get feedback on my "cheatsheet" of online resour
A fascinating - and a formative - chart, although it reflects the Top 15 global pharma. https://t.co/kFZlWF3Pcq